UA91508C2 - Fused heterocyclic compound - Google Patents

Fused heterocyclic compound

Info

Publication number
UA91508C2
UA91508C2 UAA200614049A UAA200614049A UA91508C2 UA 91508 C2 UA91508 C2 UA 91508C2 UA A200614049 A UAA200614049 A UA A200614049A UA A200614049 A UAA200614049 A UA A200614049A UA 91508 C2 UA91508 C2 UA 91508C2
Authority
UA
Ukraine
Prior art keywords
optionally substituted
bonded
compound
rmay
carbon
Prior art date
Application number
UAA200614049A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Томоясу Ишикава
Такахико Танигучи
Хироши Банно
Масаки Сето
Original Assignee
Такеда Фармасьютикал Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Такеда Фармасьютикал Компани Лимитед filed Critical Такеда Фармасьютикал Компани Лимитед
Publication of UA91508C2 publication Critical patent/UA91508C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

A compound represented by the formula (I) [wherein W represents C(R) or N; A represents optionally substituted aryl or optionally substituted heteroaryl; Xrepresents -NR-Y4 -O-, -S-, -SO-, -SO-, or -CHR- (wherein Rrepresents hydrogen or an optionally substituted aliphatic hydrocarbon group, provided that Rmay be bonded to A to form an optionally substituted ring structure); Rrepresents hydrogen or an optionally substituted group bonded through a carbon, nitrogen, or oxygen atom; and Rrepresents hydrogen or an optionally substituted group bonded through a carbon or sulfur atom, provided that Rmay be bonded to Ror Rto form an optionally substituted ring structure] or a salt of the compound. Also provided is a tyrosinkinase inhibitor or a preventive/therapeutic agent for cancers which each contains the compound or a prodrug thereof.(I)
UAA200614049A 2004-06-02 2005-06-01 Fused heterocyclic compound UA91508C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004165050 2004-06-02

Publications (1)

Publication Number Publication Date
UA91508C2 true UA91508C2 (en) 2010-08-10

Family

ID=38214911

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200614049A UA91508C2 (en) 2004-06-02 2005-06-01 Fused heterocyclic compound

Country Status (3)

Country Link
CN (1) CN1993362B (en)
UA (1) UA91508C2 (en)
ZA (1) ZA200610669B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9944649B2 (en) * 2014-05-01 2018-04-17 Novartis Ag Compounds and compositions as toll-like receptor 7 agonists
CA2946408C (en) * 2014-05-01 2020-04-28 Novartis Ag Compounds and compositions as toll-like receptor 7 agonists
CN105732635A (en) * 2014-12-29 2016-07-06 南京明德新药研发股份有限公司 Toll-like receptor 7 agonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69531558T2 (en) * 1995-06-07 2004-03-18 Pfizer Inc. HETEROCYCLIC CONDENSED PYRIMIDINE DERIVATIVES
JP2000505109A (en) * 1996-11-27 2000-04-25 ファイザー・インク Fused bicyclic pyrimidine derivatives
US6187777B1 (en) * 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases

Also Published As

Publication number Publication date
CN1993362B (en) 2010-12-15
CN1993362A (en) 2007-07-04
ZA200610669B (en) 2008-06-25

Similar Documents

Publication Publication Date Title
TW200611907A (en) Fused heterocyclic compound
TW200718686A (en) Pharmaceutical compounds
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
SG163617A1 (en) Macrocyclic inhibitors of hepatitis c virus
TW200633991A (en) Chemical compounds
MX344669B (en) Novel anti-platelet agent.
TW200602319A (en) Indole derivative and use thereof
NO20062633L (en) Pyrazole derivatives as protein kinase modulators
MX2009010024A (en) Novel adenine compound.
WO2006136837A3 (en) Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators
UA83243C2 (en) Compounds having inhibitory activity against sodium-dependant transporter
RS20060041A (en) Carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists
MX2009012885A (en) Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity.
UA95255C2 (en) Azole and thiazole derivatives and their use
TW200745034A (en) New compounds
MXPA05013209A (en) 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators.
MY150269A (en) Novel phenylpyrrole derivative
MY159910A (en) Pyrrolidin-2-one derivatives as androgen receptor modulator
TNSN07397A1 (en) Acetylene derivatives
MX2009007954A (en) Heterocyclidene-n-(aryl)acetamide derivative.
MY149180A (en) Uracil compound having inhibitor activity on human deoxyuridine triphosphatase or salt thereof
MY145066A (en) Methods for treating sexual dysfunction
AR047531A1 (en) DERIVATIVES 1H-TIENO (2,3-C) PIRAZOL USEFUL AS QUINASE INHIBITORS
BRPI0510335A (en) heterocyclic compound
MX2010001566A (en) Aminopyrazole amide derivative.